103 related articles for article (PubMed ID: 32819792)
1. Early and long-term effect of the treatment with pyridostigmine in patients with GMPPB-related congenital myasthenic syndrome.
Bobadilla-Quesada EJ; Natera-de Benito D; Carrera-García L; Ortez C; Exposito-Escudero J; Jimenez-Mallebrera C; Jou C; Codina A; Corbera J; Moya O; Saez V; Gonzalez-Quereda L; Gallano P; Colomer J; Cuadras D; Medina J; Yoldi ME; Nascimento A
Neuromuscul Disord; 2020 Sep; 30(9):719-726. PubMed ID: 32819792
[TBL] [Abstract][Full Text] [Related]
2. Novel mutations in the C-terminal region of GMPPB causing limb-girdle muscular dystrophy overlapping with congenital myasthenic syndrome.
Luo S; Cai S; Maxwell S; Yue D; Zhu W; Qiao K; Zhu Z; Zhou L; Xi J; Lu J; Beeson D; Zhao C
Neuromuscul Disord; 2017 Jun; 27(6):557-564. PubMed ID: 28433477
[TBL] [Abstract][Full Text] [Related]
3. Two patients with GMPPB mutation: The overlapping phenotypes of limb-girdle myasthenic syndrome and limb-girdle muscular dystrophy dystroglycanopathy.
Montagnese F; Klupp E; Karampinos DC; Biskup S; Gläser D; Kirschke JS; Schoser B
Muscle Nerve; 2017 Aug; 56(2):334-340. PubMed ID: 27874200
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal degradation of GMPPB is associated with limb-girdle muscular dystrophy type 2T.
Tian WT; Zhou HY; Zhan FX; Zhu ZY; Yang J; Chen SD; Luan XH; Cao L
Ann Clin Transl Neurol; 2019 Jun; 6(6):1062-1071. PubMed ID: 31211170
[TBL] [Abstract][Full Text] [Related]
5. A founder mutation in the GMPPB gene [c.1000G > A (p.Asp334Asn)] causes a mild form of limb-girdle muscular dystrophy/congenital myasthenic syndrome (LGMD/CMS) in South Indian patients.
Polavarapu K; Mathur A; Joshi A; Nashi S; Preethish-Kumar V; Bardhan M; Sharma P; Parveen S; Seth M; Vengalil S; Chawla T; Shingavi L; Shamim U; Nayak S; Vivekanand A; Töpf A; Roos A; Horvath R; Lochmüller H; Nandeesh B; Arunachal G; Nalini A; Faruq M
Neurogenetics; 2021 Oct; 22(4):271-285. PubMed ID: 34333724
[TBL] [Abstract][Full Text] [Related]
6. Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.
Belaya K; Rodríguez Cruz PM; Liu WW; Maxwell S; McGowan S; Farrugia ME; Petty R; Walls TJ; Sedghi M; Basiri K; Yue WW; Sarkozy A; Bertoli M; Pitt M; Kennett R; Schaefer A; Bushby K; Parton M; Lochmüller H; Palace J; Muntoni F; Beeson D
Brain; 2015 Sep; 138(Pt 9):2493-504. PubMed ID: 26133662
[TBL] [Abstract][Full Text] [Related]
7. Late-onset limb-girdle muscular dystrophy caused by GMPPB mutations.
Balcin H; Palmio J; Penttilä S; Nennesmo I; Lindfors M; Solders G; Udd B
Neuromuscul Disord; 2017 Jul; 27(7):627-630. PubMed ID: 28478914
[TBL] [Abstract][Full Text] [Related]
8. Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study.
Astrea G; Romano A; Angelini C; Antozzi CG; Barresi R; Battini R; Battisti C; Bertini E; Bruno C; Cassandrini D; Fanin M; Fattori F; Fiorillo C; Guerrini R; Maggi L; Mercuri E; Morani F; Mora M; Moro F; Pezzini I; Picillo E; Pinelli M; Politano L; Rubegni A; Sanseverino W; Savarese M; Striano P; Torella A; Trevisan CP; Trovato R; Zaraieva I; Muntoni F; Nigro V; D'Amico A; Santorelli FM;
Orphanet J Rare Dis; 2018 Sep; 13(1):170. PubMed ID: 30257713
[TBL] [Abstract][Full Text] [Related]
9. GMPPB-Associated Dystroglycanopathy: Emerging Common Variants with Phenotype Correlation.
Jensen BS; Willer T; Saade DN; Cox MO; Mozaffar T; Scavina M; Stefans VA; Winder TL; Campbell KP; Moore SA; Mathews KD
Hum Mutat; 2015 Dec; 36(12):1159-63. PubMed ID: 26310427
[TBL] [Abstract][Full Text] [Related]
10. Expanding the phenotype of GMPPB mutations.
Cabrera-Serrano M; Ghaoui R; Ravenscroft G; Johnsen RD; Davis MR; Corbett A; Reddel S; Sue CM; Liang C; Waddell LB; Kaur S; Lek M; North KN; MacArthur DG; Lamont PJ; Clarke NF; Laing NG
Brain; 2015 Apr; 138(Pt 4):836-44. PubMed ID: 25681410
[TBL] [Abstract][Full Text] [Related]
11. GDP-Mannose Pyrophosphorylase B (
Chompoopong P; Milone M
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833299
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of the myasthenic syndrome arising from mutations in GMPPB.
Rodríguez Cruz PM; Belaya K; Basiri K; Sedghi M; Farrugia ME; Holton JL; Liu WW; Maxwell S; Petty R; Walls TJ; Kennett R; Pitt M; Sarkozy A; Parton M; Lochmüller H; Muntoni F; Palace J; Beeson D
J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):802-9. PubMed ID: 27147698
[TBL] [Abstract][Full Text] [Related]
13. Mobility shift of beta-dystroglycan as a marker of
Sarkozy A; Torelli S; Mein R; Henderson M; Phadke R; Feng L; Sewry C; Ala P; Yau M; Bertoli M; Willis T; Hammans S; Manzur A; Sframeli M; Norwood F; Rakowicz W; Radunovic A; Vaidya SS; Parton M; Walker M; Marino S; Offiah C; Farrugia ME; Mamutse G; Marini-Bettolo C; Wraige E; Beeson D; Lochmüller H; Straub V; Bushby K; Barresi R; Muntoni F
J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):762-768. PubMed ID: 29437916
[TBL] [Abstract][Full Text] [Related]
14. Distinct and Recognisable Muscle MRI Pattern in a Series of Adults Harbouring an Identical GMPPB Gene Mutation.
Siddiqui S; Polavarapu K; Bardhan M; Preethish-Kumar V; Joshi A; Nashi S; Vengalil S; Raju S; Chawla T; Leena S; Mathur A; Nayak S; Mohan D; Shamim U; Prasad C; Lochmüller H; Faruq M; Nalini A
J Neuromuscul Dis; 2022; 9(1):95-109. PubMed ID: 34633329
[TBL] [Abstract][Full Text] [Related]
15. Limb-girdle muscular dystrophy due to GMPPB mutations: A case report and comprehensive literature review.
Sun L; Shen D; Xiong T; Zhou Z; Lu X; Cui F
Bosn J Basic Med Sci; 2020 May; 20(2):275-280. PubMed ID: 30684953
[TBL] [Abstract][Full Text] [Related]
16. Steroid therapy in an alpha-dystroglycanopathy due to GMPPB gene mutations: A case report.
Fecarotta S; Gragnaniello V; Della Casa R; Romano A; Raiano E; Torella A; Savarese M; Nigro V; Strisciuglio P; Andria G; Parenti G
Neuromuscul Disord; 2018 Nov; 28(11):956-960. PubMed ID: 30126629
[TBL] [Abstract][Full Text] [Related]
17. A TOR1AIP1 variant segregating with an early onset limb girdle myasthenia-Support for the role of LAP1 in NMJ function and disease.
Malfatti E; Catchpool T; Nouioua S; Sihem H; Fournier E; Carlier RY; Cardone N; Davis MR; Laing NG; Sternberg D; Ravenscroft G
Neuropathol Appl Neurobiol; 2022 Feb; 48(1):e12743. PubMed ID: 34164833
[TBL] [Abstract][Full Text] [Related]
18. Congenital muscular dystrophies in the UK population: Clinical and molecular spectrum of a large cohort diagnosed over a 12-year period.
Sframeli M; Sarkozy A; Bertoli M; Astrea G; Hudson J; Scoto M; Mein R; Yau M; Phadke R; Feng L; Sewry C; Fen ANS; Longman C; McCullagh G; Straub V; Robb S; Manzur A; Bushby K; Muntoni F
Neuromuscul Disord; 2017 Sep; 27(9):793-803. PubMed ID: 28688748
[TBL] [Abstract][Full Text] [Related]
19. Congenital myasthenic syndrome due to DOK7 mutation in a cohort of patients with 'unexplained' limb-girdle muscular weakness.
Lorenzoni PJ; Kay CSK; Arndt RC; Hrysay NMC; Ducci RD; Fustes OHJ; Töpf A; Lochmüller H; Werneck LC; Scola RH
J Clin Neurosci; 2020 May; 75():195-198. PubMed ID: 32238315
[TBL] [Abstract][Full Text] [Related]
20. A homozygous mutation in GMPPB leads to centronuclear myopathy with combined pre- and postsynaptic defects of neuromuscular transmission.
Nicolau S; Liewluck T; Shen XM; Selcen D; Engel AG; Milone M
Neuromuscul Disord; 2019 Aug; 29(8):614-617. PubMed ID: 31378432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
